Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
2016 ◽
Vol 60
(7)
◽
pp. 4384-4386
◽
ABSTRACTTo better understand the antibacterial activity of S-649266 against carbapenemase producers, its stability against clinically relevant carbapenemases was investigated. The catalytic efficiencies (kcat/Km) of IMP-1, VIM-2, and L1 for S-649266 were 0.0048, 0.0050, and 0.024 μM−1s−1, respectively, which were more than 260-fold lower than that for meropenem. Only slight hydrolysis of S-649266 against KPC-3 was observed. NDM-1 hydrolyzed meropenem 3-fold faster than S-649266 at 200 μM.
2021 ◽
Vol 21
(5)
◽
pp. 2879-2891
1996 ◽
Vol 59
(9)
◽
pp. 955-962
◽
Keyword(s):
2009 ◽
Vol 19
(14)
◽
pp. 3721-3724
◽